Thrombocytopenia and increased risk of adverse outcome in COVID-19 patients
Background Thrombocytopenia was common in the coronavirus disease 2019 (COVID-19) patients during the infection, while the role of thrombocytopenia in COVID-19 pathogenesis and its relationship with systemic host response remained obscure. The study aimed to systematically evaluate the relationship...
Main Authors: | Yang Yuan, Gang Wang, Xi Chen, Xiao-Lei Ye, Xiao-Kun Li, Rui Li, Wan-Li Jiang, Hao-Long Zeng, Juan Du, Xiao-Ai Zhang, Hao Li, Li-Qun Fang, Qing-Bin Lu, Wei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-06-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/13608.pdf |
Similar Items
-
Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia
by: Hamzah R, et al.
Published: (2022-06-01) -
Rickettsia typhi infection in severe fever with thrombocytopenia patients, China
by: Shao-Fei Zhang, et al.
Published: (2019-01-01) -
Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia
by: Meng Chan, et al.
Published: (2021-08-01) -
Clinical importance of thrombocytopenia in patients with acute coronary syndromes: a systematic review and meta-analysis
by: Vanessa Discepola, et al.
Published: (2019-10-01) -
Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS
by: Xinju Zhao, et al.
Published: (2022-01-01)